Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Gait adaptability in people with mild multiple sclerosis

Official title: Multidimensional Assessment of Gait Adaptability in Persons Multiple Sclerosis With no to Mild Disability

Run by Hasselt University · NCT07580820 · Data updated 2026-11-12

This project tests how well adults with mild multiple sclerosis can adapt their walking to changing challenges compared with healthy adults using walking tasks, wearable sensors, and questionnaires.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment32 (estimated)
SponsorHasselt University
Academic / other
Locations1 site (Diepenbeek)
StatusRecruiting
StartedDecember 5, 2025
Main results expectedSeptember 1, 2026
Study endsDecember 20, 2026
Registry record updatedMay 12, 2026
Trial IDNCT07580820 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with a confirmed diagnosis of MS, relapse-free for at least 30 days, and an EDSS score between 0 and 3.5 are ideal candidates.

Probably not a fit

People with more advanced disability (EDSS >3.5), other neurological/orthopedic/visual conditions that affect gait, or cognitive decline that prevents completing tests are unlikely to benefit from these measurements.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study will recruit 16 adults with mild MS (EDSS 0–3.5) and 16 age- and sex-matched healthy controls for a single in-person testing session at Hasselt University's REVAL center. Participants will complete timed motor tests (e.g., Timed 25‑Foot Walk, Six-Spot Step Test, 6‑Minute Walk), balance assessments (Mini-BESTest), cognitive tests (SDMT, BVMT-R), and self-report questionnaires on fatigue, walking, and balance confidence. Proactive gait adaptability will be probed using an overground Walking Adaptability Ladder Test with progressively smaller stepping targets, while wearable movement sensors record kinematics; reactive responses will be examined with appropriate perturbation and obstacle tasks. Data will be compared between groups to characterize adaptability deficits and their relationships with fatigue, cognition, and fall-related measures.

Why it matters

Potential benefit: If successful, this work could help clinicians detect subtle walking and balance problems earlier so rehabilitation and fall-prevention strategies can be better targeted.

How similar studies have gone: Previous studies using sensor-based gait measures and adaptability tasks in MS and older adults have shown promise at revealing subtle deficits, though these methods are not yet routine in clinical care.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18-65 years,
* confirmed diagnosis of definite MS,
* relapse free at least 30 days,
* Expanded Disability Status Scale (EDSS) score between 0 and 3.5

Exclusion Criteria:

* Diagnosed with neurological disease other than MS
* cognitive decline that renders the patient incapable of performing tests and questionnaires.
* Other neurological, orthopedic, or visual impairments affecting gait

Where it's running

  • REVAL Rehabilitation Research Center, University of Hasselt
    Diepenbeek, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.